Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CAPR
Stock Latest News
Company Announcements
Capricor’s Earnings Call: Deramiocel Drives High-Stakes Pivot
12d ago
CAPR
Premium
Pre-Earnings
CAPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
CAPR
Premium
Company Announcements
Capricor Faces Revenue Risk as Dependence on Nippon Shinyaku Puts Deramiocel Commercialization in Jeopardy
17d ago
CAPR
Premium
The Fly
Capricor Therapeutics price target lowered to $38 from $43 at Roth Capital
17d ago
CAPR
Premium
Ratings
Analyst Reiterates Buy on Capricor Ahead of Key 2026 PDUFA, Maintains $60 Price Target
18d ago
CAPR
Premium
The Fly
FDA Commissioner Marty Makary resigns
19d ago
AZN
BMY
Premium
The Fly
Capricor Therapeutics options imply 9.4% move in share price post-earnings
19d ago
CAPR
Premium
Ratings
Capricor Buy Rating Reiterated on Deramiocel Opportunity and NS Pharma Dispute Dynamics; $50 Price Target Maintained
19d ago
CAPR
Premium
The Fly
Capricor files suit against NS Pharma over Deramiocel distribution deal
23d ago
CAPR
Premium
Company Announcements
Capricor Sues NS Pharma Over Deramiocel U.S. Rights
24d ago
8K
CAPR
Premium
Market News
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 3/30/26, According to Analysts
2M ago
XEL
CAPR
Premium
The Fly
Capricor Therapeutics price target raised to $43 from $41 at Roth Capital
2M ago
CAPR
Premium
Company Announcements
Capricor Therapeutics Nears Key Milestones After Earnings Call
3M ago
CAPR
Premium
The Fly
Capricor selloff today a buying opportunity, says Roth Capital
3M ago
CAPR
Premium
The Fly
Capricor Therapeutics price target raised to $51 from $48 at Alliance Global
3M ago
CAPR
Premium
The Fly
Capricor Therapeutics price target raised to $63 from $50 at B. Riley
3M ago
CAPR
Premium
The Fly
Capricor Therapeutics price target raised to $58 from $45 at Piper Sandler
3M ago
CAPR
Premium
The Fly
Capricor Therapeutics reports Q4 EPS (62c), consensus (55c)
3M ago
CAPR
Premium
The Fly
Capricor Therapeutics options imply 4.2% move in share price post-earnings
3M ago
CAPR
Premium
Ratings
Deramiocel’s De‑Risked Path to Approval and Expanded DMD Opportunity Underpin Buy on CAPR
3M ago
CAPR
Premium
The Fly
Capricor announces additional analyses, outcomes from Phase 3 HOPE-3 trial
3M ago
CAPR
Premium
The Fly
Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
3M ago
ABM
CNC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
